These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. European exploitation of biotechnology-do government policies help? A recent survey of public spending on biotechnology in Europe suggests that money alone cannot stimulate growth of the sector. Senker J; Enzing C; Joly PB; Reiss T Nat Biotechnol; 2000 Jun; 18(6):605-8. PubMed ID: 10835596 [No Abstract] [Full Text] [Related]
14. Biotech parks proliferate, despite concerns over sustainability. Jia H; Jayaraman KS; Orellana C Nat Biotechnol; 2003 Nov; 21(11):1259-60. PubMed ID: 14595344 [No Abstract] [Full Text] [Related]
15. Japanese council urges reform of funding system. Triendl R Nat Biotechnol; 2002 Dec; 20(12):1176-8. PubMed ID: 12454656 [No Abstract] [Full Text] [Related]
16. Biotechnology in Ireland: hard work, money and the brain gain. O'Neill MF Drug Discov Today; 2007 Feb; 12(3-4):108-11. PubMed ID: 17275730 [No Abstract] [Full Text] [Related]
18. Harvesting biotechnology. Dennis C; Byrne N Nature; 2004 Jun; 429(6991 Suppl):1. PubMed ID: 15175703 [No Abstract] [Full Text] [Related]
19. Basic and applied research in India: present and future. Ramasami T; Rao AV; Natesh S Biotechnol J; 2009 Mar; 4(3):301-5. PubMed ID: 19296436 [No Abstract] [Full Text] [Related]
20. More than the sum of their parts? Clustering is becoming more prevalent in the biosciences, despite concerns over the sustainability and economic effectiveness of science parks and hubs. Rinaldi A EMBO Rep; 2006 Feb; 7(2):133-6. PubMed ID: 16452923 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]